LinkDoc Technology, a Chinese healthcare data company specializing in oncology patients, postponed its IPO on Thursday. The company had been expected to price its IPO on Thursday night. It had filed to raise $200 million by offering 10.8 million shares at a price range of $17.50 to $19.50. Insiders and anchor investors had indicated an interest in buying 58% of the deal. On Wednesday, LinkDoc filed an amendment where it added risks related to China's new capital markets regulation and oversight, which had been issued by the country's regulator the day before. The news comes amid China's latest crackdown of its domestic internet companies, which has most recently focused on US listings. Days after DiDi Global's ( DIDI) $4.4 billion US IPO, the regulator announced that it was pulling DiDi's app from the app store until it came under compliance with certain data security requirements, causing the stock to crash. So far this year, 31 Chinese issuers have raised $12.3 billion in US IPOs, more than all of last year, representing roughly 15% of the US IPO market by deal count and proceeds.īacked by Alibaba Health, LinkDoc Technology provides a platform that structures cancer patient data to enable precision medicine and personalized care. LinkDoc Technology, which is a China-based company that leverages sophisticated data technologies for oncology patients, was expected to pull off its IPO last week. The company's product suite includes a digital continuous care platform for patients with critical diseases, an AI-enabled curation system for longitudinal medical data, and a precision life sciences platform for clinical research. Yu Jianjun, the co-founder and chief executive of podcast start-up Ximalaya FM. LinkDoc's decision to suspend its US211 million (S285.5 million) IPO, is likely to be followed by others, analysts said, although they noted that US listings were not barred per se. The Beijing, China-based company was founded in 2014 and booked $154 million in sales for the 12 months ended March 31, 2021. In China, podcasting has also gained in popularity. The total number of podcast listeners surged to 425 million last year, compared with 348 million in 2017, according to data from iiMedia Research. At Ximalaya, the average user spends 150 minutes a day on the app. It had planned to list on the Nasdaq under the symbol LDOC. So far this year, a record US$12.5 billion by Chinese firms has been raised from 34 US listings, Refinitiv data shows, well up from the US$1.9 billion from 14 deals in the same period a year ago.Įight Chinese companies including home service platform Daojia Ltd and Atour Lifestyle Holdings have made public filings with the Securities and Exchange Commission (SEC) to list in the US later this year, a review of the filings showed.Morgan Stanley, BofA Securities, CICC, Tiger Brokers, and Snowball Securities were set to be the joint bookrunners on the deal. US capital markets have been a lucrative source of funding for Chinese firms in the past decade, especially for technology companies looking to benchmark their valuations against listed peers there and tap an abundant liquidity pool. The company did not disclose a specific value for its offering but listed it in the filing as 100. Morgan Stanley and Bank of America declined to comment, while CICC did not respond to a Reuters request for comment. CHINABASED XIMALAYA LINKDOC US IPOTIMES REGISTRATION. Morgan Stanley, Bank of America, and China International Capital Corp Ltd (CICC) were the investment banks on the deal. LinkDoc did not immediately respond to a request for comment. The sources declined to be identified as the information has not yet been made public. The book closed one day earlier than planned on Wednesday, one of the three sources and a separate person said. Polyalkylene glycol (PEGs) are a type of plastic that is used in a wide variety of products polyethylene terephthalate (PET), polyethylene (PE), polyvinyl chloride (PVC), polystyrene, and polypropylene. It had planned to sell 10.8 million shares between US$17.50 and US$19.50 each.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |